MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹6.31 Cr | ₹29 Cr | ₹4.30 Cr | ₹5.84 Cr | ₹19 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹6.31 Cr |
Mar2023 | ₹29 Cr |
Mar2022 | ₹4.30 Cr |
Mar2021 | ₹5.84 Cr |
Mar2020 | ₹19 Cr |
How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹6.31 Cr | -78.32 | |
Mar2023 | ₹29 Cr | 577.69 | |
Mar2022 | ₹4.30 Cr | -26.39 | |
Mar2021 | ₹5.84 Cr | -69.37 | |
Mar2020 | ₹19 Cr | - |
Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹562.8 Cr | 2.7% | -11.2% | -28.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | -1.6% | -6% | 46.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,306.0 Cr | 0.4% | 3.9% | 64% | Stock Analytics | |
CIPLA | ₹120,459.0 Cr | 1.8% | 0.2% | 17.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,168.0 Cr | 0.5% | -7.9% | 6.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,662.7 Cr | 0.7% | -4% | 48.3% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 2.7% |
-11.2% |
-28.9% |
SENSEX | 3.4% |
0.2% |
21.7% |
You may also like the below Video Courses